FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2573710850> ?p ?o ?g. }

• W2573710850 endingPage "12982" @default.
• W2573710850 startingPage "12968" @default.
• W2573710850 abstract "Head and neck squamous cell carcinoma (HNSCC) is one of the most common and aggressive types of human cancers worldwide. Nearly a half of HNSCC patients experience recurrence within five years of treatment and develop resistance to chemotherapy. Thus, there is an urgent clinical need to develop safe and novel anticancer therapies for HNSCC. Here, we investigate the possibility of repurposing the anthelmintic drug mebendazole (MBZ) as an anti-HNSCC agent. Using the two commonly-used human HNSCC lines CAL27 and SCC15, we demonstrate MBZ exerts more potent anti-proliferation activity than cisplatin in human HNSCC cells. MBZ effectively inhibits cell proliferation, cell cycle progression and cell migration, and induces apoptosis of HNSCC cells. Mechanistically, MBZ can modulate the cancer-associated pathways including ELK1/SRF, AP1, STAT1/2, MYC/MAX, although the regulatory outcomes are context-dependent. MBZ also synergizes with cisplatin in suppressing cell proliferation and inducing apoptosis of human HNSCC cells. Furthermore, MBZ is shown to promote the terminal differentiation of CAL27 cells and keratinization of CAL27-derived xenograft tumors. Our results are the first to demonstrate that MBZ may exert its anticancer activity by inhibiting proliferation while promoting differentiation of certain HNSCC cancer cells. It's conceivable the anthelmintic drug MBZ can be repurposed as a safe and effective agent used in combination with other frontline chemotherapy drugs such as cisplatin in HNSCC treatment." @default.
• W2573710850 created "2017-01-26" @default.
• W2573710850 creator A5001780997 @default.
• W2573710850 creator A5002287326 @default.
• W2573710850 creator A5006173892 @default.
• W2573710850 creator A5012217069 @default.
• W2573710850 creator A5017274582 @default.
• W2573710850 creator A5023214008 @default.
• W2573710850 creator A5027475930 @default.
• W2573710850 creator A5028086544 @default.
• W2573710850 creator A5029042665 @default.
• W2573710850 creator A5032716483 @default.
• W2573710850 creator A5036173674 @default.
• W2573710850 creator A5048671685 @default.
• W2573710850 creator A5049680501 @default.
• W2573710850 creator A5050212938 @default.
• W2573710850 creator A5051915881 @default.
• W2573710850 creator A5054020363 @default.
• W2573710850 creator A5055022742 @default.
• W2573710850 creator A5058661277 @default.
• W2573710850 creator A5060470951 @default.
• W2573710850 creator A5062902141 @default.
• W2573710850 creator A5070578608 @default.
• W2573710850 creator A5072743477 @default.
• W2573710850 creator A5075996643 @default.
• W2573710850 creator A5077610728 @default.
• W2573710850 creator A5079286604 @default.
• W2573710850 creator A5081842504 @default.
• W2573710850 creator A5082490654 @default.
• W2573710850 creator A5090513264 @default.
• W2573710850 date "2017-01-16" @default.
• W2573710850 modified "2023-10-17" @default.
• W2573710850 title "Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)" @default.
• W2573710850 cites W1587594315 @default.
• W2573710850 cites W1591707748 @default.
• W2573710850 cites W1654551777 @default.
• W2573710850 cites W1729228772 @default.
• W2573710850 cites W1819379772 @default.
• W2573710850 cites W1861029200 @default.
• W2573710850 cites W1900399885 @default.
• W2573710850 cites W1974896778 @default.
• W2573710850 cites W1984308718 @default.
• W2573710850 cites W1990956554 @default.
• W2573710850 cites W1999125418 @default.
• W2573710850 cites W2013668655 @default.
• W2573710850 cites W2022936070 @default.
• W2573710850 cites W2023292535 @default.
• W2573710850 cites W2033707323 @default.
• W2573710850 cites W2045233171 @default.
• W2573710850 cites W2048375025 @default.
• W2573710850 cites W2050660850 @default.
• W2573710850 cites W2061623393 @default.
• W2573710850 cites W2064318532 @default.
• W2573710850 cites W2067713829 @default.
• W2573710850 cites W2072755256 @default.
• W2573710850 cites W2074347542 @default.
• W2573710850 cites W2082905522 @default.
• W2573710850 cites W2084016524 @default.
• W2573710850 cites W2087466845 @default.
• W2573710850 cites W2090641109 @default.
• W2573710850 cites W2091728033 @default.
• W2573710850 cites W2094134393 @default.
• W2573710850 cites W2096439168 @default.
• W2573710850 cites W2099044540 @default.
• W2573710850 cites W2100614336 @default.
• W2573710850 cites W2100657952 @default.
• W2573710850 cites W2116144169 @default.
• W2573710850 cites W2120071860 @default.
• W2573710850 cites W2120166815 @default.
• W2573710850 cites W2120927552 @default.
• W2573710850 cites W2121987769 @default.
• W2573710850 cites W2123187034 @default.
• W2573710850 cites W2123845167 @default.
• W2573710850 cites W2124275237 @default.
• W2573710850 cites W2131597845 @default.
• W2573710850 cites W2145108050 @default.
• W2573710850 cites W2147188402 @default.
• W2573710850 cites W2153156463 @default.
• W2573710850 cites W2153301032 @default.
• W2573710850 cites W2162098634 @default.
• W2573710850 cites W2165385965 @default.
• W2573710850 cites W2169668331 @default.
• W2573710850 cites W2171910732 @default.
• W2573710850 cites W2172019818 @default.
• W2573710850 cites W2183709609 @default.
• W2573710850 cites W2195407532 @default.
• W2573710850 cites W2239758289 @default.
• W2573710850 cites W2300348392 @default.
• W2573710850 cites W2315265027 @default.
• W2573710850 cites W2322806394 @default.
• W2573710850 cites W2336527613 @default.
• W2573710850 cites W2338107694 @default.
• W2573710850 cites W2346266138 @default.
• W2573710850 cites W2396850828 @default.
• W2573710850 cites W2411216265 @default.
• W2573710850 cites W2412880611 @default.
• W2573710850 cites W2605187236 @default.
• W2573710850 cites W751460208 @default.

• next